Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 52.25% is in line with its 5-year average of 54.15%, near the low end of its 5-year range (49.80%–58.56%).
As of the fiscal period ended Tuesday, March 31, 2026. 0.53% above its 12-month average of 51.98%.
Reported quarterly gross margin; no daily interpolation.
GROSS MARGIN
52.25%
GROSS MARGIN AVG TTM
51.98%
GROSS MARGIN AVG 3Y
53.01%
GROSS MARGIN AVG 5Y
54.15%
GROSS MARGIN AVG 10Y
54.48%
GROSS MARGIN AVG 15Y
54.94%
GROSS MARGIN AVG 20Y
55.09%
CURRENT VS TTM AVG
+0.53%
CURRENT VS 3Y AVG
-1.43%
CURRENT VS 5Y AVG
-3.49%
CURRENT VS 10Y AVG
-4.09%
CURRENT VS 15Y AVG
-4.89%
CURRENT VS 20Y AVG
-5.15%
SECTOR MEDIAN · HEALTHCARE
58.51%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-10.69%
vs the sector median at left
Bio-Rad Laboratories, Inc.
Market Cap
$8.85B
Gross Margin
52.25%
TTM Avg
51.98%
3Y Avg
53.01%
5Y Avg
54.15%
Market Cap
$10.18B
Gross Margin
90.45%
TTM Avg
90.21%
3Y Avg
89.67%
5Y Avg
89.38%
Market Cap
$10.37B
Gross Margin
17.13%
TTM Avg
18.71%
3Y Avg
19.98%
5Y Avg
20.79%
Market Cap
$10.39B
Gross Margin
13.07%
TTM Avg
12.36%
3Y Avg
12.43%
5Y Avg
12.55%
Market Cap
$11.28B
Gross Margin
64.96%
TTM Avg
65.60%
3Y Avg
66.84%
5Y Avg
66.79%
Market Cap
$11.31B
Gross Margin
31.86%
TTM Avg
31.70%
3Y Avg
34.15%
5Y Avg
35.17%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bio-Rad Laboratories, Inc. (BIO) | $8.85B | 52.25% | 51.98% | 53.01% | 54.15% |
| Oscar Health, Inc. (OSCR)vs › | $7.93B | 17.39% | 17.24% | 38.82% | 59.22% |
| Henry Schein, Inc. (HSIC)vs › | $9.78B | 29.69% | 29.43% | 29.32% | 29.12% |
| Universal Health Services, Inc. (UHS)vs › | $10.18B | 90.45% | 90.21% | 89.67% | 89.38% |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | 17.13% | 18.71% | 19.98% | 20.79% |
| Molina Healthcare, Inc. (MOH)vs › | $10.39B | 13.07% | 12.36% | 12.43% | 12.55% |
| Tempus AI, Inc. (TEM)vs › | $7.27B | 69.55% | 62.30% | 54.75% | 44.45% |
| Bio-Techne Corporation (TECH)vs › | $11.28B | 64.96% | 65.60% | 66.84% | 66.79% |
| Charles River Laboratories International, Inc. (CRL)vs › | $11.31B | 31.86% | 31.70% | 34.15% | 35.17% |
| Insulet Corp. (PODD)vs › | $11.82B | 71.01% | 70.71% | 67.87% | 67.39% |
Gross Margin
52.3%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-03-31 | 52.25% |
| 2025-12-31 | 49.80% |
| 2025-09-30 | 52.59% |
| 2025-06-30 | 52.99% |
| 2025-03-31 | 52.27% |
| 2024-12-31 | 51.22% |
| 2024-09-30 | 54.78% |
| 2024-06-30 | 55.62% |
| 2024-03-31 | 53.45% |
| 2023-12-31 | 53.72% |
| 2023-09-30 | 53.10% |
| 2023-06-30 | 53.22% |
| 2023-03-31 | 53.55% |
| 2022-12-31 | 54.38% |
| 2022-09-30 | 54.90% |
| 2022-06-30 | 57.30% |
| 2022-03-31 | 57.51% |
| 2021-12-31 | 54.72% |
| 2021-09-30 | 58.56% |
| 2021-06-30 | 56.09% |
| 2021-03-31 | 55.12% |
| 2020-12-31 | 58.26% |
| 2020-09-30 | 56.75% |
| 2020-06-30 | 54.57% |
| 2020-03-31 | 55.52% |
| 2019-12-31 | 52.92% |
| 2019-09-30 | 54.76% |
| 2019-06-30 | 53.75% |
| 2019-03-31 | 56.28% |
| 2018-12-31 | 54.05% |
| 2018-09-30 | 52.60% |
| 2018-06-30 | 52.38% |
| 2018-03-31 | 54.79% |
| 2017-12-31 | 54.73% |
| 2017-09-30 | 56.92% |
| 2017-06-30 | 54.15% |
| 2017-03-31 | 53.99% |
| 2016-12-31 | 55.01% |
| 2016-09-30 | 54.93% |
| 2016-06-30 | 54.23% |
| 2016-03-31 | 56.03% |
| 2015-12-31 | 54.07% |
| 2015-09-30 | 56.06% |
| 2015-06-30 | 55.25% |
| 2015-03-31 | 57.13% |
| 2014-12-31 | 53.06% |
| 2014-09-30 | 54.38% |
| 2014-06-30 | 55.37% |
| 2014-03-31 | 54.05% |
| 2013-12-31 | 53.56% |
| 2013-09-30 | 56.27% |
| 2013-06-30 | 57.13% |
| 2013-03-31 | 54.32% |
| 2012-12-31 | 55.95% |
| 2012-09-30 | 54.84% |
| 2012-06-30 | 56.40% |
| 2012-03-31 | 57.29% |
| 2011-12-31 | 56.51% |
| 2011-09-30 | 57.34% |
| 2011-06-30 | 56.19% |
| 2011-03-31 | 57.23% |
| 2010-12-31 | 56.16% |
| 2010-09-30 | 56.49% |
| 2010-06-30 | 57.37% |
| 2010-03-31 | 56.61% |
| 2009-12-31 | 54.23% |
| 2009-09-30 | 56.50% |
| 2009-06-30 | 56.64% |
| 2009-03-31 | 57.09% |
| 2008-12-31 | 55.07% |
| 2008-09-30 | 54.44% |
| 2008-06-30 | 54.92% |
| 2008-03-31 | 53.74% |
| 2007-12-31 | 50.82% |
| 2007-09-30 | 55.44% |
| 2007-06-30 | 56.03% |
| 2007-03-31 | 55.62% |
| 2006-12-31 | 54.09% |
| 2006-09-30 | 54.73% |
| 2006-06-30 | 58.12% |
| 2006-03-31 | 56.93% |
| 2005-12-31 | 52.92% |
| 2005-09-30 | 55.37% |
| 2005-06-30 | 55.15% |
| 2005-03-31 | 55.62% |
| 2004-12-31 | 54.68% |
| 2004-09-30 | 55.17% |
| 2004-06-30 | 57.44% |
| 2004-03-31 | 56.55% |
| 2003-12-31 | 55.92% |
| 2003-09-30 | 55.48% |
| 2003-06-30 | 56.02% |
| 2003-03-31 | 58.02% |
| 2002-12-31 | 56.31% |
| 2002-09-30 | 57.38% |
| 2002-06-30 | 56.96% |
